[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-344649-en":59,"doc-seo-344649-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":72,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},344649,1099513958762,"Logic","https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Subsequent risk of non-keratinocyte skin cancers in adult cancer survivors: a SEER-based cohort study","Objective characterise the risk of subsequent primary non-keratinocyte skin cancers (NKSCs) among adult-onset cancer survivors. Using population-based SEER data from 17 registries (2000-2021), survivors of first primary cancers aged 20–84 were followed from September to November 2024. Incidence increases were assessed via standardised incidence rates (SIR) and excess risk analysis across cancer types and treatments. Several primary cancers, especially after radiotherapy or chemotherapy, showed markedly elevated NKSC risks. Conclusions emphasise continuous surveillance and proactive prevention to mitigate subsequent primary NKSC development.","Open access  \nTo cite: Jiayuan L, Luo Z, Guo Z, et al. Subsequent risk of nonkeratinocyte skin cancers in adult cancer survivors: a SEERbased cohort study. BMJ Open 2026;16:e104815 . doi:10 . 1136/ bmjopen-2025-104815  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2025-104815](bmjopen-2025-104815)) .  \nLJ and ZL contributed equally.  \nReceived 08 May 2025 Accepted 14 January 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Department of Dermatology, Central South University, Changsha, Hunan, China 2Central South University, Changsha, Hunan, China 3Xiangya Hospital Central South University, Changsha, Hunan, China  \n4Plastic Surgery, Xiangya Hospital Central South University, Changsha, China 5Xiangya Hospital Central South University, Changsha, China  \nCorrespondence to  \nDr Furong Zeng; zengflorachn@hotmail.com and Dr Yuming Sun; [962881298@qq.com](962881298@qq.com)  \nOriginal research  \nSubsequent risk of non-keratinocyte skin cancers in adult cancer survivors: a SEER-based cohort study  \nLe Jiayuan,1,2 Zehao Luo,3 Ziyu Guo,3 Danyao Chen,3 Guangtong Deng  1  \n,  \nShengchao Xu,3 Lei Yao,3 Yuming Sun,4 Furong Zeng  5  \nABSTRACT  \nObjective To characterise the risk of subsequent primary non-keratinocyte skin cancers (NKSCs) among adult-onset cancer survivors.  \nDesign Data analysis of this population-based cohort study was conducted from September to November 2024.  \nSetting The data are based on 17 Surveillance, Epidemiology and End Results (SEER) registries from 2000 to 2021.  \nParticipants Survivors of first primary cancers diagnosed in individuals aged 20–84 years between 2000 and 2021, across 17 registries in the SEER Program  \nPrimary and secondary outcome and measure Primary outcomes were a statistically significant increase in the incidence of subsequent NKSCs. Standardised incidence rate (SIR) and excess risk analysis were used to evaluate the risk of subsequent NKSCs after different primary cancers.  \nResults Among 5 691 336 survivors (51 .3% male),  \n31 529 subsequent NKSCs were observed during a total follow-up of 36 440 569 person-years (mean, 6.4 years) . The risk of subsequent NKSCs was increased after the first primary cancer (SIR, 1.12 (95% CI 1.10 to 1 . 13)) . Across 35 first primary cancers, 19 showed a statistically significant rise in subsequent NKSC incidence. The highest SIR for subsequent NKSCs was observed after eye and orbit cancer (SIR, 2.96 (95% CI 2.55 to 3 .41)), followed by cutaneous melanoma (SIR, 2.67 (95% CI 2.41 to 2 .94)) and chronic lymphocytic leukaemia (SIR, 2.24 (95% CI 2.10 to 2.38)) . Across NKSC types, cancer survivors were more likely to develop subsequent hemangiosarcoma (SIR, 2.66 (95% CI 2.31 to 3 .05)), adenocarcinoma, not otherwise specified (SIR, 2.14 (95% CI 1.53 to 2 .91)) and sebaceous adenocarcinoma (SIR, 1.70 (95% CI 1.57 to 1 .83)) . 10 specific first primary cancers demonstrated a consistently high risk of several specific NKSCs throughout the study period. Furthermore, the risk of subsequent NKSCs among cancer survivors was largely elevated following radiotherapy or chemotherapy (range, 13%–18%), especially for hemangiosarcoma.  \nConclusions and relevance Several types of primary cancers were strongly linked to an increased risk of subsequent NKSCs, underscoring the critical importance of implementing continuous surveillance and proactive prevention strategies to mitigate the risk of developing subsequent primary NKSCs among cancer survivors.  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ This study utilised a large, nationally representative dataset from 17 Surveillance, Epidemiology, and End Results (SEER) registries, encompassing over 5.6 million adult-onset cancer su","cbCaif2Xkjo7a1mx","https://ap.wps.com/l/cbCaif2Xkjo7a1mx","pdf",3487942,11,"English","en",105,"# Abstract\n## Objective\n## Design and setting\n## Participants and outcomes\n## Results\n## Conclusions and relevance\n# Strengths and limitations\n# Introduction","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To characterise the risk of subsequent primary non-keratinocyte skin cancers among adult-onset cancer survivors.\"},{\"question\":\"How was the study designed and what data source was used?\",\"answer\":\"A population-based cohort analysis used SEER registry data from 17 registries covering 2000 to 2021.\"},{\"question\":\"Which factors were associated with higher risk of subsequent NKSCs?\",\"answer\":\"The risk increased after certain first primary cancers and was largely elevated following radiotherapy or chemotherapy, with particularly high increases for hemangiosarcoma.\"}]","Subsequent risk of non-keratinocyte skin cancers in adult cancer survivors: a SEER-based cohort study | PDF",1790054761,25,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0c579231feac7cb8acc9e2ceff85931.webp",983,1310,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67cfc1298974fb410b50dfcec2103d22.webp",982,1309,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e894014c09cb611237788810a456bccc.webp",981,1308,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80c0c233072d609b6b3f451ba2271b30.webp",980,1306,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"subsequent-risk-of-non-keratinocyte-skin-cancers-in-adult-cancer-survivors-a-seer-based-cohort-study","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/subsequent-risk-of-non-keratinocyte-skin-cancers-in-adult-cancer-survivors-a-seer-based-cohort-study/344649/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/subsequent-risk-of-non-keratinocyte-skin-cancers-in-adult-cancer-survivors-a-seer-based-cohort-study/344649.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":72},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What is the main objective of the study?","Question",{"text":146,"@type":147},"To characterise the risk of subsequent primary non-keratinocyte skin cancers among adult-onset cancer survivors.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How was the study designed and what data source was used?",{"text":151,"@type":147},"A population-based cohort analysis used SEER registry data from 17 registries covering 2000 to 2021.",{"name":153,"@type":144,"acceptedAnswer":154},"Which factors were associated with higher risk of subsequent NKSCs?",{"text":155,"@type":147},"The risk increased after certain first primary cancers and was largely elevated following radiotherapy or chemotherapy, with particularly high increases for hemangiosarcoma.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790122415]